BRPI0510104A8 - Imunização contra sorogrupo meningocócico y que usa proteínas - Google Patents
Imunização contra sorogrupo meningocócico y que usa proteínasInfo
- Publication number
- BRPI0510104A8 BRPI0510104A8 BRPI0510104A BRPI0510104A BRPI0510104A8 BR PI0510104 A8 BRPI0510104 A8 BR PI0510104A8 BR PI0510104 A BRPI0510104 A BR PI0510104A BR PI0510104 A BRPI0510104 A BR PI0510104A BR PI0510104 A8 BRPI0510104 A8 BR PI0510104A8
- Authority
- BR
- Brazil
- Prior art keywords
- serogroup
- immunization against
- meningococical
- serogroups
- immunization
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Abstract
IMUNIZAÇÃO CONTRA SOROGRUPO MENINGOCÓCICO Y QUE USA PROTEÍNAS O dogma estabelecido para o meningococo é, portanto, que a imunização contra sorogrupos A, C, W135 e Y deve ser baseada nos quatro sacarídeos capsulares diferentes, e que a imunização contra sorogrupo B não deve ser baseada eno sacarídeo capsular. Em contraste, a invenção usa antígenos polipeptídicos e/ou OMVs para imunizar contra sorogrupos A, C, W135 e Y (e contra sorogrupo Y em particular). Polipeptídeos de sorogrupo B podem atingir essa proteção assim permitindo que uma vacina baseada em polipeptídeo único possa ser usada para proteção contra todos os sorogrupos A, B, C, W135 e Y.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0408977.7A GB0408977D0 (en) | 2004-04-22 | 2004-04-22 | Immunising against meningococcal serogroup Y using proteins |
PCT/IB2005/001279 WO2005102384A2 (en) | 2004-04-22 | 2005-04-22 | Immunising against meningococcal serogroup y using proteins |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI0510104A BRPI0510104A (pt) | 2007-09-25 |
BRPI0510104A8 true BRPI0510104A8 (pt) | 2018-04-03 |
Family
ID=32344210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0510104A BRPI0510104A8 (pt) | 2004-04-22 | 2005-04-22 | Imunização contra sorogrupo meningocócico y que usa proteínas |
Country Status (14)
Country | Link |
---|---|
US (1) | US10195264B2 (pt) |
EP (1) | EP1737486B2 (pt) |
JP (2) | JP4918479B2 (pt) |
CN (1) | CN1946420B (pt) |
AU (1) | AU2005235265A1 (pt) |
BR (1) | BRPI0510104A8 (pt) |
CA (1) | CA2566509C (pt) |
CY (1) | CY1114179T1 (pt) |
ES (1) | ES2401481T5 (pt) |
GB (1) | GB0408977D0 (pt) |
MX (1) | MXPA06012041A (pt) |
PT (1) | PT1737486E (pt) |
RU (1) | RU2378009C2 (pt) |
WO (1) | WO2005102384A2 (pt) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7368261B1 (en) | 1999-04-30 | 2008-05-06 | Novartis Vaccines And Diagnostics Srl | Conserved Neisserial antigens |
DK2270173T3 (en) | 1999-05-19 | 2016-03-07 | Glaxosmithkline Biolog Sa | Neisserial combination compositions |
CN1800385B (zh) * | 2000-02-28 | 2010-06-02 | 启龙有限公司 | 奈瑟球菌蛋白质的异源表达 |
MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
PT2255826E (pt) * | 2002-08-02 | 2016-06-08 | Glaxosmithkline Biologicals Sa | Composições de vacina de neisseria compreendendo uma combinação de antigénios |
ES2608048T3 (es) * | 2002-10-11 | 2017-04-05 | Glaxosmithkline Biologicals Sa | Vacunas polipeptídicas para protección amplia contra linajes meningocócicos hipervirulentos |
GB0408977D0 (en) * | 2004-04-22 | 2004-05-26 | Chiron Srl | Immunising against meningococcal serogroup Y using proteins |
NZ594482A (en) * | 2005-11-04 | 2012-11-30 | Novartis Vaccines & Diagnostic | Influenza vaccines with reduced amount of oil-in-water emulsion as adjuvant |
GB0524066D0 (en) * | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
AR058707A1 (es) | 2005-12-22 | 2008-02-20 | Glaxosmithkline Biolog Sa | Vacuna, procedimiento para fabricarla y su uso |
AR064642A1 (es) | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
EA200901578A1 (ru) | 2007-06-26 | 2010-08-30 | Глаксосмитклайн Байолоджикалс С.А. | Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae |
AU2010227219B2 (en) | 2009-03-24 | 2014-02-27 | Glaxosmithkline Biologicals S.A. | Adjuvanting meningococcal factor H binding protein |
JP5668049B2 (ja) * | 2009-03-24 | 2015-02-12 | ノバルティス アーゲー | 髄膜炎菌h因子結合タンパク質および肺炎球菌糖結合体の組み合わせ |
CA2772104A1 (en) * | 2009-08-27 | 2011-03-03 | Novartis Ag | Hybrid polypeptides including meningococcal fhbp sequences |
WO2011027956A2 (ko) | 2009-09-04 | 2011-03-10 | 주식회사이언메딕스 | 그람 양성 박테리아에서 유래한 세포밖 소포체 및 이를 이용한 질병 모델 |
EP2494865A4 (en) | 2009-09-01 | 2014-05-14 | Aeon Medix Inc | EXTRACELLULAR VESICLES OBTAINED FROM THE DARMFLORA, AND METHOD FOR SEARCHING FOR A DISEASE MODEL, VACCINE AND CANDIDATE AND DIAGNOSTIC METHOD THEREFOR |
ES2910199T3 (es) | 2010-03-30 | 2022-05-11 | Childrens Hospital & Res Center At Oakland | Proteínas de unión al factor H (fHbp) con propiedades alteradas y métodos de uso de las mismas |
HUE052850T2 (hu) | 2010-08-23 | 2021-05-28 | Wyeth Llc | Neisseria meningitidis RLP2086 antigéneket tartalmazó stabil készítmények |
NZ607224A (en) | 2010-09-10 | 2014-11-28 | Wyeth Llc | Non-lipidated variants of neisseria meningitidis orf2086 antigens |
SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
KR101763625B1 (ko) | 2012-03-09 | 2017-08-01 | 화이자 인코포레이티드 | 수막염균 조성물 및 이의 사용 방법 |
NZ630133A (en) * | 2012-06-14 | 2016-10-28 | Novartis Ag | Vaccines for serogroup x meningococcus |
WO2014016152A1 (en) | 2012-07-27 | 2014-01-30 | Institut National De La Sante Et De La Recherche Medicale | Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia |
ES2685894T3 (es) | 2013-03-08 | 2018-10-15 | Pfizer Inc. | Polipéptidos de fusión inmunogénicos |
RU2662968C2 (ru) | 2013-09-08 | 2018-07-31 | Пфайзер Инк. | Иммуногенная композиция против neisseria meningitidis (варианты) |
EP4074726A3 (en) | 2014-07-23 | 2022-11-23 | Children's Hospital & Research Center at Oakland | Factor h binding protein variants and methods of use thereof |
EP3270959A1 (en) | 2015-02-19 | 2018-01-24 | Pfizer Inc | Neisseria meningitidis compositions and methods thereof |
CA3035320A1 (en) | 2016-09-02 | 2018-03-08 | Glaxosmithkline Biologicals Sa | Vaccines for neisseria gonorrhoeae |
SG11201906519RA (en) | 2017-01-31 | 2019-08-27 | Pfizer | Neisseria meningitidis compositions and methods thereof |
Family Cites Families (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4309095A (en) | 1980-11-03 | 1982-01-05 | Buckley Frederick P | Camera mounting device |
US4356170A (en) | 1981-05-27 | 1982-10-26 | Canadian Patents & Development Ltd. | Immunogenic polysaccharide-protein conjugates |
US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
US4459286A (en) | 1983-01-31 | 1984-07-10 | Merck & Co., Inc. | Coupled H. influenzae type B vaccine |
US4663160A (en) | 1983-03-14 | 1987-05-05 | Miles Laboratories, Inc. | Vaccines for gram-negative bacteria |
US4761283A (en) | 1983-07-05 | 1988-08-02 | The University Of Rochester | Immunogenic conjugates |
US4808700A (en) | 1984-07-09 | 1989-02-28 | Praxis Biologics, Inc. | Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers |
EP0273116A3 (en) | 1986-10-09 | 1990-05-02 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Gonococcal and meningococcal polypeptides, vaccines and diagnostics |
NO882936D0 (no) * | 1987-07-07 | 1988-07-01 | Nl Mini Welzijn Gesund Cultur | Flerverdig meningokokkvaksine. |
RU2023448C1 (ru) | 1987-07-30 | 1994-11-30 | Сентро Насьональ Де Биопрепарадос | Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в |
US4835621A (en) | 1987-11-04 | 1989-05-30 | Black John W | Gun mounted video camera |
NL8802046A (nl) | 1988-08-18 | 1990-03-16 | Gen Electric | Polymeermengsel met polyester en alkaansulfonaat, daaruit gevormde voorwerpen. |
NL8803111A (nl) | 1988-12-19 | 1990-07-16 | Nederlanden Staat | Multivalent meningococcen klasse i buitenmembraaneiwit vaccin. |
AU640118B2 (en) | 1988-12-19 | 1993-08-19 | De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezonheid En Cultuur | Meningococcal class 1 outer-membrane protein vaccine |
DK130889A (da) | 1989-03-17 | 1990-09-18 | Mogens Kilian | Immunoglobulin a1-proteaser (iga1-proteaser), fremgangsmaade til genteknologisk fremstilling af saadanne enzymer samt vaccine indeholdende enzymerne og fragmenter deraf til immunisering mod bakteriel meningitis og andre sygdomme fremkaldt af iga1-protease-producerende bakterier |
IE912559A1 (en) | 1990-07-19 | 1992-01-29 | Merck & Co Inc | The class ii protein of the outer membrane of neisseria¹meningitidis, and vaccines containing same |
US5020262A (en) | 1990-09-04 | 1991-06-04 | Pena Louis T | Camera mount for rifle scopes |
CA2105382C (en) | 1991-03-14 | 1999-01-19 | Neil Goldstein | Recombinant hybrid porin epitopes |
FR2692592B1 (fr) | 1992-06-19 | 1995-03-31 | Pasteur Merieux Serums Vacc | Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant. |
NL9201716A (nl) | 1992-10-02 | 1994-05-02 | Nederlanden Staat | Buitenmembraanvesikel dat voorzien is van een groep polypeptiden welke ten minste de immuunwerking van aan membraan gebonden buitenmembraaneiwitten (OMP's) hebben, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk buitenmembraanvesikel omvat. |
US5439808A (en) | 1993-07-23 | 1995-08-08 | North American Vaccine, Inc. | Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis |
FR2720408B1 (fr) | 1994-05-31 | 1996-08-14 | Pasteur Merieux Serums Vacc | Fragments Tbp2 de Neisseria meningitidis. |
IL117483A (en) | 1995-03-17 | 2008-03-20 | Bernard Brodeur | MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K. |
US6180111B1 (en) | 1995-05-18 | 2001-01-30 | University Of Maryland | Vaccine delivery system |
FR2739624B1 (fr) | 1995-10-10 | 1997-12-05 | Pasteur Merieux Serums Vacc | Nouvelle sous-unite tbp2 de neisseria meningitidis |
EP0939647B2 (en) | 1996-08-27 | 2006-07-12 | Chiron Corporation | Neisseria meningitidis serogroup b glycoconjugates and methods of using the same |
US6472518B1 (en) | 1996-10-24 | 2002-10-29 | Centers For Disease Control And Prevention, As Represented By The Secretary, Department Of Health And Human Services | Invasion associated genes from Neisseria meningitidis serogroup B |
GB9711964D0 (en) | 1997-06-09 | 1997-08-06 | Medical Res Council | Live attenuated vaccines |
US6914131B1 (en) | 1998-10-09 | 2005-07-05 | Chiron S.R.L. | Neisserial antigens |
ATE476508T1 (de) | 1997-11-06 | 2010-08-15 | Novartis Vaccines & Diagnostic | Neisseriale antigene |
US5887375A (en) | 1997-11-19 | 1999-03-30 | Watson; Jerry Wade | Camera mount for firearms |
GB9726398D0 (en) | 1997-12-12 | 1998-02-11 | Isis Innovation | Polypeptide and coding sequences |
EP2210945B1 (en) | 1998-01-14 | 2013-06-26 | Novartis Vaccines and Diagnostics S.r.l. | Neisseria meningitidis antigens |
US20070026021A1 (en) * | 1998-05-01 | 2007-02-01 | Chiron S.R.I. | Neisseria meningitidis antigens and compositions |
NZ508366A (en) | 1998-05-01 | 2004-03-26 | Chiron Corp | Neisseria meningitidis antigens and compositions |
BR9914374A (pt) * | 1998-10-09 | 2002-09-17 | Chiron Corp | Sequências genÈmicas de neisseria e métodos para seu uso |
US6146902A (en) | 1998-12-29 | 2000-11-14 | Aventis Pasteur, Inc. | Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions |
US6425697B1 (en) | 1999-03-17 | 2002-07-30 | Jeff C. Potts | Universal camera mounting assembly |
JP2003527079A (ja) | 1999-04-30 | 2003-09-16 | カイロン コーポレイション | ナイセリアゲノム配列およびそれらの使用方法 |
US7368261B1 (en) | 1999-04-30 | 2008-05-06 | Novartis Vaccines And Diagnostics Srl | Conserved Neisserial antigens |
DK2270173T3 (en) * | 1999-05-19 | 2016-03-07 | Glaxosmithkline Biolog Sa | Neisserial combination compositions |
US6192614B1 (en) | 1999-07-23 | 2001-02-27 | Daniel Cliburn | Video mounting system for firearm |
GB9918319D0 (en) | 1999-08-03 | 1999-10-06 | Smithkline Beecham Biolog | Vaccine composition |
MXPA02004283A (es) | 1999-10-29 | 2002-10-17 | Chiron Spa | Peptidos antigenicos neisseriales. |
GB9928196D0 (en) * | 1999-11-29 | 2000-01-26 | Chiron Spa | Combinations of B, C and other antigens |
CN1433471A (zh) * | 1999-11-29 | 2003-07-30 | 启龙股份公司 | 85kgDa奈瑟球菌的抗原 |
DK1248647T3 (da) * | 2000-01-17 | 2010-09-27 | Novartis Vaccines & Diagnostic | Ydre membranvesikel (OMV) vaccine omfattende N. meningitidis serogruppe B ydre membranproteiner |
CZ304379B6 (cs) | 2000-01-25 | 2014-04-09 | The University Of Queensland | Proteiny obsahující konzervované oblasti povrchového antigenu NhhA z Neisseria meningitidis |
CN1800385B (zh) | 2000-02-28 | 2010-06-02 | 启龙有限公司 | 奈瑟球菌蛋白质的异源表达 |
MXPA03000822A (es) | 2000-07-27 | 2004-11-01 | Childrens Hosp & Res Ct Oak | Vacunas para proteccion de espectro amplio contra enfermedades causadas por neisseria meningitidis. |
GB0103170D0 (en) | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
CA2435681C (en) | 2001-01-23 | 2011-06-21 | Aventis Pasteur | Multivalent meningococcal polysaccharide-protein conjugate vaccine |
GB0103171D0 (en) | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
GB0115176D0 (en) | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
EP1409013B1 (en) * | 2001-07-26 | 2009-11-18 | Novartis Vaccines and Diagnostics S.r.l. | Vaccines comprising aluminium adjuvants and histidine |
GB0118249D0 (en) * | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
GB0121591D0 (en) | 2001-09-06 | 2001-10-24 | Chiron Spa | Hybrid and tandem expression of neisserial proteins |
ES2615362T3 (es) | 2001-07-27 | 2017-06-06 | Glaxosmithkline Biologicals Sa | Adhesinas de meningococos |
AR045702A1 (es) | 2001-10-03 | 2005-11-09 | Chiron Corp | Composiciones de adyuvantes. |
MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
PT2255826E (pt) | 2002-08-02 | 2016-06-08 | Glaxosmithkline Biologicals Sa | Composições de vacina de neisseria compreendendo uma combinação de antigénios |
GB0220197D0 (en) | 2002-08-30 | 2002-10-09 | Univ Utrecht | Refolding method |
US7785608B2 (en) * | 2002-08-30 | 2010-08-31 | Wyeth Holdings Corporation | Immunogenic compositions for the prevention and treatment of meningococcal disease |
ES2608048T3 (es) * | 2002-10-11 | 2017-04-05 | Glaxosmithkline Biologicals Sa | Vacunas polipeptídicas para protección amplia contra linajes meningocócicos hipervirulentos |
GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
EP1590459A2 (en) | 2003-01-15 | 2005-11-02 | Wyeth Holdings Corporation | Methods for increasing neisseria protein expression and compositions thereof |
CA2514328C (en) | 2003-01-30 | 2020-01-14 | Chiron Srl | Injectable vaccines against multiple meningococcal serogroups |
JP2006525330A (ja) | 2003-04-16 | 2006-11-09 | ワイエス・ホールディングス・コーポレーション | 髄膜炎菌性疾患の予防および処置のための新規免疫原性組成物 |
US7731967B2 (en) | 2003-04-30 | 2010-06-08 | Novartis Vaccines And Diagnostics, Inc. | Compositions for inducing immune responses |
GB0315021D0 (en) * | 2003-06-26 | 2003-07-30 | Chiron Srl | Immunogenic gonococcal compositions |
DK1961426T3 (da) * | 2003-10-02 | 2011-08-08 | Novartis Ag | Kombinationsvacciner mod meningitis |
GB0408977D0 (en) * | 2004-04-22 | 2004-05-26 | Chiron Srl | Immunising against meningococcal serogroup Y using proteins |
GB0409748D0 (en) | 2004-04-30 | 2004-06-09 | Chiron Srl | Lactoferrin cleavage |
GB0419408D0 (en) * | 2004-09-01 | 2004-10-06 | Chiron Srl | 741 chimeric polypeptides |
GB0419627D0 (en) * | 2004-09-03 | 2004-10-06 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
CN101107007B (zh) | 2005-01-27 | 2011-08-17 | 奥克兰儿童医院及研究中心 | 对脑膜炎奈瑟球菌所致疾病具有广谱保护作用的gna1870囊泡疫苗 |
CA2611960C (en) * | 2005-06-27 | 2015-05-05 | Glaxosmithkline Biologicals S.A. | Immunogenic compositions comprising n.meningitidis capsular saccharide conjugates |
GB0524066D0 (en) | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
TW200806315A (en) | 2006-04-26 | 2008-02-01 | Wyeth Corp | Novel formulations which stabilize and inhibit precipitation of immunogenic compositions |
BRPI0713904A2 (pt) * | 2006-06-29 | 2013-06-25 | Novartis Ag | polipeptÍdeos a partir de neisseria meningitidis |
US7491517B2 (en) * | 2006-07-19 | 2009-02-17 | Jeeri R Reddy | Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135 |
AR064642A1 (es) | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
US20100150912A1 (en) | 2007-04-11 | 2010-06-17 | Novartis Ag | Blocking interaction between pathogen factors and factor h to inhibit hemorrhagic syndromes |
MX2009013112A (es) | 2007-06-04 | 2010-03-01 | Novartis Ag | Formulacion de vacunas para meningitis. |
CA2716212A1 (en) | 2008-02-21 | 2009-08-27 | Novartis Ag | Meningococcal fhbp polypeptides |
EP2265640B1 (en) | 2008-03-10 | 2015-11-04 | Children's Hospital & Research Center at Oakland | Chimeric factor h binding proteins (fhbp) containing a heterologous b domain and methods of use |
US20100035234A1 (en) * | 2008-05-19 | 2010-02-11 | Novartis Ag | Vaccine assays |
WO2010028096A2 (en) | 2008-09-03 | 2010-03-11 | Children's Hospital & Research Center At Oakland | Peptides presenting an epitope of an a domain of factor h binding protein and methods of use |
IT1394288B1 (it) | 2008-09-12 | 2012-06-06 | Novartis Vaccines & Diagnostic | Immunogeni di proteine che legano il fattore h. |
GB0819633D0 (en) | 2008-10-25 | 2008-12-03 | Isis Innovation | Composition |
AU2010227219B2 (en) | 2009-03-24 | 2014-02-27 | Glaxosmithkline Biologicals S.A. | Adjuvanting meningococcal factor H binding protein |
JP2013521327A (ja) | 2010-03-10 | 2013-06-10 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 免疫原性組成物 |
ES2910199T3 (es) | 2010-03-30 | 2022-05-11 | Childrens Hospital & Res Center At Oakland | Proteínas de unión al factor H (fHbp) con propiedades alteradas y métodos de uso de las mismas |
AU2011300418B2 (en) | 2010-09-10 | 2016-05-12 | Glaxosmithkline Biologicals Sa | Meningococcus overexpressing NadA and/or NHBA and outer membrane vesicles derived therefrom |
-
2004
- 2004-04-22 GB GBGB0408977.7A patent/GB0408977D0/en not_active Ceased
-
2005
- 2005-04-22 CN CN2005800127317A patent/CN1946420B/zh active Active
- 2005-04-22 CA CA2566509A patent/CA2566509C/en active Active
- 2005-04-22 JP JP2007509008A patent/JP4918479B2/ja active Active
- 2005-04-22 ES ES05733998T patent/ES2401481T5/es active Active
- 2005-04-22 BR BRPI0510104A patent/BRPI0510104A8/pt not_active Application Discontinuation
- 2005-04-22 MX MXPA06012041A patent/MXPA06012041A/es active IP Right Grant
- 2005-04-22 US US11/587,189 patent/US10195264B2/en active Active
- 2005-04-22 WO PCT/IB2005/001279 patent/WO2005102384A2/en active Application Filing
- 2005-04-22 RU RU2006140958/13A patent/RU2378009C2/ru not_active IP Right Cessation
- 2005-04-22 PT PT57339988T patent/PT1737486E/pt unknown
- 2005-04-22 EP EP05733998.8A patent/EP1737486B2/en active Active
- 2005-04-22 AU AU2005235265A patent/AU2005235265A1/en not_active Abandoned
-
2011
- 2011-03-03 JP JP2011046993A patent/JP2011105777A/ja not_active Withdrawn
-
2013
- 2013-04-29 CY CY20131100353T patent/CY1114179T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
MXPA06012041A (es) | 2007-01-25 |
WO2005102384A2 (en) | 2005-11-03 |
JP2011105777A (ja) | 2011-06-02 |
JP4918479B2 (ja) | 2012-04-18 |
CY1114179T1 (el) | 2016-08-31 |
GB0408977D0 (en) | 2004-05-26 |
JP2007533729A (ja) | 2007-11-22 |
EP1737486B2 (en) | 2022-12-28 |
WO2005102384A3 (en) | 2006-03-23 |
US20100143418A1 (en) | 2010-06-10 |
AU2005235265A1 (en) | 2005-11-03 |
RU2006140958A (ru) | 2008-05-27 |
RU2378009C2 (ru) | 2010-01-10 |
PT1737486E (pt) | 2013-05-15 |
US10195264B2 (en) | 2019-02-05 |
CN1946420B (zh) | 2011-02-16 |
EP1737486A2 (en) | 2007-01-03 |
ES2401481T5 (es) | 2023-05-16 |
BRPI0510104A (pt) | 2007-09-25 |
CA2566509C (en) | 2018-07-17 |
EP1737486B1 (en) | 2013-02-27 |
CN1946420A (zh) | 2007-04-11 |
ES2401481T3 (es) | 2013-04-22 |
CA2566509A1 (en) | 2005-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0510104A8 (pt) | Imunização contra sorogrupo meningocócico y que usa proteínas | |
BRPI0407101A (pt) | Vacinas meningocócicas mucosais | |
BRPI1009828A2 (pt) | adjuvante de proteína de ligação de fator h meningocócica | |
MX348734B (es) | Vacunacion multiple que incluye meningococcus del serogrupo c. | |
CR10123A (es) | Vacuna. | |
BRPI0510430A (pt) | composições e métodos para vacinação mucosal | |
BRPI0619795B8 (pt) | composição imunogênica, composição adjuvante, e, uso de uma composição imunogênica e um adjuvante | |
ATE552844T1 (de) | Injizierbarer impfstoff gegen multiple meningokokken-serogruppen | |
DK2200642T3 (da) | Meningococvaccinepræparater | |
BR0310042A (pt) | Vacinas de combinação mucosal para meningite bacteriana | |
WO2005032583A3 (en) | Liquid vaccines for multiple meningococcal serogroups | |
RU2017123262A (ru) | Иммуногенные композиции для применения в пневмококковых вакцинах | |
NZ562998A (en) | Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages | |
JP2007533729A5 (pt) | ||
BRPI0612670B8 (pt) | composição imunogênica, vacina a compreendendo e kit de vacina para a administração concomitante ou sequencial | |
BR122020000250B8 (pt) | dispositivos para administração de fármaco | |
BRPI0510315A (pt) | integração de vacinação com conjugado meningocócico | |
BRPI0512854A (pt) | terapia adjuvante aperfeiçoada para tumores que expressam g250 | |
BRPI0408518A (pt) | terapia combinada compreendendo nemorubicin e um inibidor de ciclooxigenase-2 | |
WO2004075811A3 (es) | Composiciones vacunales a base de gangliósidos para administración subcutánea | |
WO2005023295A3 (en) | Naturally processed immunodominant peptides derived from neisseria meningitidis porin a protein and their use | |
UA91701C2 (ru) | Мультивалентная иммуногенная композиция против гриппа, которая включает антиген вируса гриппа и адъювант на основе эмульсии масла-в-воде |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25D | Requested change of name of applicant approved |
Owner name: NOVARTIS VACCINES AND DIAGNOSTICS S.R.L. (IT) Free format text: ALTERADO DE: CHIRON S.R.L. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B25D | Requested change of name of applicant approved |
Owner name: GSK VACCINES S.R.L. (IT) |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |